相关实验视频
Updated: Jul 18, 2025

08:16
One-anastomosis Gastric Bypass OAGB in Rats
Published on: November 10, 2018
11.0K
胃切除术后持久性低血糖症 胃癌患者的不知觉,由前性研究揭示
Takeshi Kubota1, Masayuki Yubakami1, Emi Ushigome2
1From the Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, Japan.
概括
胃癌的胃切除术后,持续的低血糖和无意识是常见的,即使是一年后. 长期监测血糖趋势对于管理胃切除术后综合征至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
背景情况:
- 晚期倾倒综合征是一种胃切除术后的并发症,与反应性低血糖症有关.
- 随着时间的推移,血糖趋势及其与胃切除术后症状的关联尚未被彻底评估.
研究的目的:
- 为了探索胃切除术后胃癌患者的血糖趋势.
- 为了澄清血糖趋势随时间变化的变化,与胃切除术后的症状有关.
主要方法:
- 对71名接受治疗性胃切除术的胃癌患者进行前性研究.
- 手术后1个月和12个月的持续血糖监测.
- 评估使用胃切除术后综合征评估尺度 (PGSAS-37) 在1,6和12个月.
主要成果:
- 低血糖,特别是夜间的低血糖,在胃切除术后的12个月内持续存在.
- 血糖变异性增加,而PGSAS-37症状得分保持不变.
- 低血糖缺乏意识是显而易见的,即使没有典型的症状.
结论:
- 持续的胃切除术后低血糖缺乏意识是胃切除术后综合征的一个重要问题.
- 精心长期评估血糖趋势和患者护理是必不可少的.
相关概念视频
Hypoglycemia and Glucagon
296
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
296
Peptic Ulcer Disease V: Surgical Management and Nursing Care
335
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
335
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
199
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
199
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
205
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
205
Gastric Emptying
919
Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
919
Endoscopic Procedures I: Esophagogastroduodenoscopy
174
An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
During an EGD, the endoscope can be used to:
174

